2008
DOI: 10.1007/2789_2008_077
|View full text |Cite
|
Sign up to set email alerts
|

In Vivo Characterization of Progestins with Reduced Non-genomic Activity In Vitro

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2008
2008
2011
2011

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 11 publications
0
1
0
Order By: Relevance
“…In this respect, membrane ER-acting agonists have been synthesized and demonstrate the contributions of membrane-localized steroid receptor signaling to transcription (49). ER modulators and progestins that are more active for nongenomic rather than genomic signaling have also recently been developed and will help address this issue (59,60). Comparable reagents for other steroid receptors will be useful to test the roles of these binding proteins in vivo.…”
Section: Perspective and Significancementioning
confidence: 99%
“…In this respect, membrane ER-acting agonists have been synthesized and demonstrate the contributions of membrane-localized steroid receptor signaling to transcription (49). ER modulators and progestins that are more active for nongenomic rather than genomic signaling have also recently been developed and will help address this issue (59,60). Comparable reagents for other steroid receptors will be useful to test the roles of these binding proteins in vivo.…”
Section: Perspective and Significancementioning
confidence: 99%